Skip to main content
. 2016 Jul 21;128(11):1449–1457. doi: 10.1182/blood-2016-05-718643

Figure 1.

Figure 1

Treatment algorithm for patients with hematologic malignancies and chronic HCV infection in 2016. aPatient had either spontaneous resolution of acute HCV, false positive anti-HCV, or sustained virologic response posttreatment; bSee text; cSpecialist on infectious diseases, hepatology, or gastroenterology; and dAs recommended in selected cases for patients without cancer as of July 2016.